NCT00092326 A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183) Status COMPLETED Phase PHASE3
NCT00092313 A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182) Status COMPLETED Phase PHASE3
NCT00092300 A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00092196 Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00092183 An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) Status COMPLETED Phase PHASE4
NCT00092170 An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038) Status COMPLETED Phase PHASE2
NCT00092079 A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) Status COMPLETED Phase PHASE3
NCT00091572 Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267) Status COMPLETED Phase PHASE3
NCT00091559 Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) Status COMPLETED Phase PHASE2
NCT00090285 An Investigational Study of Gardasilâ„¢ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) Status COMPLETED Phase PHASE3
NCT00090272 A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039) Status COMPLETED Phase PHASE3
NCT00090246 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091) Status COMPLETED Phase PHASE3
NCT00090220 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Status COMPLETED Phase PHASE3
NCT00090207 Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED) Status COMPLETED Phase PHASE4
NCT00090155 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00087516 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021) Status COMPLETED Phase PHASE3
NCT00087451 Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00086515 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00086502 Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3